These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11562179)
1. Genetic epidemiology of female breast cancer. Hopper JL Semin Cancer Biol; 2001 Oct; 11(5):367-74. PubMed ID: 11562179 [TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
3. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Simchoni S; Friedman E; Kaufman B; Gershoni-Baruch R; Orr-Urtreger A; Kedar-Barnes I; Shiri-Sverdlov R; Dagan E; Tsabari S; Shohat M; Catane R; King MC; Lahad A; Levy-Lahad E Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3770-4. PubMed ID: 16537453 [TBL] [Abstract][Full Text] [Related]
4. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?]. Bonadona V; Lasset C Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related]
6. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400 [TBL] [Abstract][Full Text] [Related]
7. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550 [TBL] [Abstract][Full Text] [Related]
8. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
9. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and molecular diagnosis of inherited breast-ovarian cancer]. Chompret A J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301 [TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Antoniou AC; Durocher F; Smith P; Simard J; Easton DF; Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652 [TBL] [Abstract][Full Text] [Related]
12. 18. Genetics of breast cancer. Irving M; Elmslie F; Berg J Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and BRCA penetrance: a case-only study. Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808 [TBL] [Abstract][Full Text] [Related]
14. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. King MC; Marks JH; Mandell JB; Science; 2003 Oct; 302(5645):643-6. PubMed ID: 14576434 [TBL] [Abstract][Full Text] [Related]
15. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204 [TBL] [Abstract][Full Text] [Related]
16. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254 [TBL] [Abstract][Full Text] [Related]
17. Molecular and pathological characterization of inherited breast cancer. Borg A Semin Cancer Biol; 2001 Oct; 11(5):375-85. PubMed ID: 11562180 [TBL] [Abstract][Full Text] [Related]
18. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Spurdle AB; Hopper JL; Chen X; Dite GS; Cui J; McCredie MR; Giles GG; Ellis-Steinborner S; Venter DJ; Newman B; Southey MC; Chenevix-Trench G Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):413-6. PubMed ID: 11927503 [TBL] [Abstract][Full Text] [Related]
19. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Antoniou AC; Shenton A; Maher ER; Watson E; Woodward E; Lalloo F; Easton DF; Evans DG Breast Cancer Res; 2006; 8(6):R72. PubMed ID: 17187672 [TBL] [Abstract][Full Text] [Related]
20. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Liede A; Karlan BY; Narod SA J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]